File:Contergan tablets.jpg: Difference between revisions

From Embryology
mNo edit summary
mNo edit summary
 
Line 1: Line 1:
==Contergan - tablet packaging==
==Contergan - tablet packaging==
Historic packaging for tablets of the drug released in Germany as "Contergan" that contained thalidomide.
Historic packaging for tablets of the sleeping tablet drug released in Germany as "Contergan", that contained thalidomide.


[[:File:Widukind Lenz.jpg|Dr Widukind Lenz]] (1919 - 1995) was a German paediatrician who in 1961 identified the association of a thalidomide drug ("Contergan") with birth abnormalities.<ref name="PMID14464041"><pubmed>14464041</pubmed></ref><ref name="PMID14464040"><pubmed>14464040</pubmed></ref><ref name="PMID3991661"><pubmed>3991661</pubmed></ref>. In Australia, a similar observation had been made independently by [[:File:William McBride.jpg|Dr William McBride]] published in a brief letter in The Lancet (16 December 1961).
[[:File:Widukind Lenz.jpg|Dr Widukind Lenz]] (1919 - 1995) was a German paediatrician who in 1961 identified the association of a thalidomide drug ("Contergan") with birth abnormalities.<ref name="PMID14464041"><pubmed>14464041</pubmed></ref><ref name="PMID14464040"><pubmed>14464040</pubmed></ref><ref name="PMID3991661"><pubmed>3991661</pubmed></ref>. In Australia, a similar observation had been made independently by [[:File:William McBride.jpg|Dr William McBride]] published in a brief letter in The Lancet (16 December 1961).

Latest revision as of 11:41, 5 April 2016

Contergan - tablet packaging

Historic packaging for tablets of the sleeping tablet drug released in Germany as "Contergan", that contained thalidomide.

Dr Widukind Lenz (1919 - 1995) was a German paediatrician who in 1961 identified the association of a thalidomide drug ("Contergan") with birth abnormalities.[1][2][3]. In Australia, a similar observation had been made independently by Dr William McBride published in a brief letter in The Lancet (16 December 1961).


Links: Abnormal Development - Thalidomide


Reference

  1. <pubmed>14464041</pubmed>
  2. <pubmed>14464040</pubmed>
  3. <pubmed>3991661</pubmed>



Cite this page: Hill, M.A. (2024, June 23) Embryology Contergan tablets.jpg. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/File:Contergan_tablets.jpg

What Links Here?
© Dr Mark Hill 2024, UNSW Embryology ISBN: 978 0 7334 2609 4 - UNSW CRICOS Provider Code No. 00098G

File history

Yi efo/eka'e gwa ebo wo le nyangagi wuncin ye kamina wunga tinya nan

GwalagizhiNyangagiDimensionsUserComment
current11:29, 5 April 2016Thumbnail for version as of 11:29, 5 April 2016523 × 223 (47 KB)Z8600021 (talk | contribs)==Contergan - tablet packaging== Dr Widukind Lenz (1919 - 1995) was a German paediatrician who in 1961 identified the association of a thalidomide drug ("Contergan") with birth abnormalities.<ref name="PMID14464041"><pubmed>14464041</pubmed></ref><ref...

The following 2 pages use this file: